Your browser doesn't support javascript.
loading
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects.
Suarez-Carmona, Meggy; Williams, Anja; Schreiber, Jutta; Hohmann, Nicolas; Pruefer, Ulrike; Krauss, Jürgen; Jäger, Dirk; Frömming, Anna; Beyer, Diana; Eulberg, Dirk; Jungelius, Jarf Ulf; Baumann, Matthias; Mangasarian, Aram; Halama, Niels.
Afiliação
  • Suarez-Carmona M; Department of Translational Immunotherapy, German Cancer Research Centre, Heidelberg, Germany.
  • Williams A; Department of Medical Oncology, National Center of Tumor Diseases, Heidelberg, Baden-Württemberg, Germany.
  • Schreiber J; Department of Medical Oncology, National Center of Tumor Diseases, Heidelberg, Baden-Württemberg, Germany.
  • Hohmann N; Department of Medical Oncology, National Center of Tumor Diseases, Heidelberg, Baden-Württemberg, Germany.
  • Pruefer U; Department of Medical Oncology, National Center of Tumor Diseases, Heidelberg, Baden-Württemberg, Germany.
  • Krauss J; Department of Medical Oncology, National Center of Tumor Diseases, Heidelberg, Baden-Württemberg, Germany.
  • Jäger D; Department of Medical Oncology, National Center of Tumor Diseases, Heidelberg, Baden-Württemberg, Germany.
  • Frömming A; NOXXON Pharma AG, Berlin, Germany.
  • Beyer D; NOXXON Pharma AG, Berlin, Germany.
  • Eulberg D; NOXXON Pharma AG, Berlin, Germany.
  • Jungelius JU; NOXXON Pharma AG, Berlin, Germany.
  • Baumann M; NOXXON Pharma AG, Berlin, Germany.
  • Mangasarian A; NOXXON Pharma AG, Berlin, Germany.
  • Halama N; Department of Translational Immunotherapy, German Cancer Research Centre, Heidelberg, Germany niels.halama@nct-heidelberg.de.
J Immunother Cancer ; 9(10)2021 10.
Article em En | MEDLINE | ID: mdl-34607895
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Colorretais / Quimiocina CXCL12 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Colorretais / Quimiocina CXCL12 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha